Clinical characteristics and correlation between hearing outcomes after different episodes of recurrent idiopathic sudden sensorineural hearing loss | Canada Hyperbarics Skip to main content
Study Auris Nasus Larynx 2021

Clinical characteristics and correlation between hearing outcomes after different episodes of recurrent idiopathic sudden sensorineural hearing loss

Wu P, Lee C, Chen H, Lee J, Chu Y, Cheng L, et al. — Auris Nasus Larynx, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This retrospective study evaluated the clinical features and correlation of hearing outcomes after first and recurrent episodes of idiopathic sudden sensorineural hearing loss (ISSNHL) in 30 patients.

What They Found

The median age at the first and second ISSNHL episodes was 48 and 53.5 years, respectively, with vertigo present in 30% of first episodes and 40% of second episodes. Complete hearing recovery rates were 46.67% after the first episode and 33.33% after the second episode, and a significant positive correlation (r = 0.721, p < 0.001) was found between treatment outcomes of the first and second episodes.

What This Means for Canadian Patients

Canadian patients experiencing recurrent idiopathic sudden sensorineural hearing loss may find that their hearing recovery after a subsequent episode is related to their recovery from the initial episode. This suggests that the outcome of the first episode could offer an indication of potential recovery in future recurrences.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.

Study Limitations

Limitations include the retrospective design and the small sample size of 30 patients, which may limit the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 33549393
Year Published 2021
Journal Auris Nasus Larynx
MeSH Terms Administration, Intravenous; Administration, Oral; Adult; Audiometry, Pure-Tone; Female; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Injection, Intratympanic; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vertigo

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.